COVID-19: Tocilizumab and Baricitinib Use in Hospitalized Patients, IL-6 Inhibitors and Mortality, Infection Relapse Following Paxlovid and Prehospital Administration of Remdesivir

76 views
May 12, 2022
0 Comments
Login to view comments. Click here to Login